Biologics: Targets and Therapy : Impact Factor & More

eISSN: 1177-5491pISSN: 1177-5475
JournalOpen Access

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Biologics: Targets and Therapy Key Metrics

CiteScore
5.7
SJR
Q2Oncology
SNIP
1.05
Time to Accept
4
 Mo
Time to Publish
time-to-publish View Chart
4
 Mo
Time to Publish

Sign up now and unlock a detailed chart of Time to publish for this journal

% of papers by time taken from submission to publication
0 to 3 months
13%
4 to 6 months
71%
7 to 9 months
16%
Above 9 months
0%

Biologics: Targets and Therapy Journal Specifications

Overview
Publisher DOVE MEDICAL PRESS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2390
Publication Time16
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2007
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Biologics: Targets and Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Biologics: Targets and Therapy

Telitacicept: A New Therapy for the Treatment of Optic Neuromyelitis Spectrum Disease Associated with Other Autoimmune Disorders.
  • 1 Apr 2025
  • Biologics : targets & therapy
RNA Sequencing Identifies Novel Signaling Pathways and Potential Drug Target Genes Induced by FOSL1 in Glioma Progression and Stemness.
  • 1 Apr 2025
  • Biologics : targets & therapy
Advancing Monoclonal Antibody Manufacturing: Process Optimization, Cost Reduction Strategies, and Emerging Technologies.
  • 1 Apr 2025
  • Biologics : targets & therapy
Telitacicept: A New Therapy for the Treatment of Optic Neuromyelitis Spectrum Disease Associated with Other Autoimmune Disorders.
  • 1 Apr 2025
  • Biologics : targets & therapy
RNA Sequencing Identifies Novel Signaling Pathways and Potential Drug Target Genes Induced by FOSL1 in Glioma Progression and Stemness.
  • 1 Apr 2025
  • Biologics : targets & therapy
Advancing Monoclonal Antibody Manufacturing: Process Optimization, Cost Reduction Strategies, and Emerging Technologies.
  • 1 Apr 2025
  • Biologics : targets & therapy

Compare Similar Journals with Biologics: Targets and Therapy

Select Journals to Compare with Biologics: Targets and Therapy
Total journals - 9
You can select up to 3 Journals at a time

Dermatologic Therapy

Publisher: WILEY-HINDAWI

eNeurologicalSci

Publisher: Elsevier

Journal of the Neurological Sciences

Publisher: ELSEVIER

Revue Neurologique

Publisher: MASSON EDITEUR

Multiple Sclerosis and Related Disorders

Publisher: ELSEVIER SCI LTD

Neurological Sciences

Publisher: SPRINGER-VERLAG ITALIA SRL

Clinical Neuropharmacology

Publisher: LIPPINCOTT WILLIAMS & WILKINS

BMC Neurology

Publisher: BMC

Journal of Neuroimmunology

Publisher: ELSEVIER
0 Journals Selected to compare with
Biologics: Targets and Therapy
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers

SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers

Get detailed Journal comparison report on your email by signing up

Check if your research matches the topics covered in Biologics: Targets and Therapy?

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Check your research

FAQs on Biologics: Targets and Therapy